Section 3(d) of Indian Patents Act
GPTKB entity
Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:law
|
| gptkbp:aimsTo |
prevent evergreening of patents
|
| gptkbp:appliesTo |
pharmaceutical patents
|
| gptkbp:dateEnacted |
2005
|
| https://www.w3.org/2000/01/rdf-schema#label |
Section 3(d) of Indian Patents Act
|
| gptkbp:interpretedBy |
Indian courts
|
| gptkbp:notableCase |
Novartis AG v. Union of India
|
| gptkbp:partOf |
Indian Patents Act, 1970
|
| gptkbp:purpose |
to prevent patenting of incremental innovations without significant efficacy
|
| gptkbp:relatedTo |
patentability criteria
|
| gptkbp:state |
the mere discovery of a new form of a known substance which does not result in the enhancement of the known efficacy of that substance is not patentable
|
| gptkbp:bfsParent |
gptkb:Mashelkar_Committee_Report
|
| gptkbp:bfsLayer |
7
|